Free Trial

Safe Pro Group (SPAI) Competitors

Safe Pro Group logo
$6.10 -0.69 (-10.09%)
As of 03:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SPAI vs. STIM, NYXH, SGHT, SI, INGN, INFU, KRMD, CVRX, MGRM, and CV

Should you be buying Safe Pro Group stock or one of its competitors? The main competitors of Safe Pro Group include Neuronetics (STIM), Nyxoah (NYXH), Sight Sciences (SGHT), Shoulder Innovations (SI), Inogen (INGN), InfuSystem (INFU), KORU Medical Systems (KRMD), CVRx (CVRX), Monogram Orthopaedics (MGRM), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.

Safe Pro Group vs. Its Competitors

Neuronetics (NASDAQ:STIM) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

Neuronetics has a net margin of -43.47% compared to Safe Pro Group's net margin of -731.46%. Neuronetics' return on equity of -156.36% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Neuronetics-43.47% -156.36% -35.69%
Safe Pro Group -731.46%-328.85%-248.09%

53.6% of Neuronetics shares are held by institutional investors. 9.8% of Neuronetics shares are held by company insiders. Comparatively, 54.8% of Safe Pro Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Neuronetics currently has a consensus price target of $7.00, indicating a potential upside of 109.96%. Safe Pro Group has a consensus price target of $8.00, indicating a potential upside of 31.04%. Given Neuronetics' higher possible upside, equities research analysts plainly believe Neuronetics is more favorable than Safe Pro Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neuronetics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Safe Pro Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Safe Pro Group has lower revenue, but higher earnings than Neuronetics. Safe Pro Group is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neuronetics$74.89M2.94-$43.71M-$1.13-2.95
Safe Pro Group$2.17M45.49-$7.43M-$0.80-7.63

In the previous week, Safe Pro Group had 8 more articles in the media than Neuronetics. MarketBeat recorded 8 mentions for Safe Pro Group and 0 mentions for Neuronetics. Safe Pro Group's average media sentiment score of 0.33 beat Neuronetics' score of 0.00 indicating that Safe Pro Group is being referred to more favorably in the news media.

Company Overall Sentiment
Neuronetics Neutral
Safe Pro Group Neutral

Summary

Neuronetics and Safe Pro Group tied by winning 8 of the 16 factors compared between the two stocks.

Get Safe Pro Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPAI vs. The Competition

MetricSafe Pro GroupTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$98.72M$2.68B$25.99B$9.75B
Dividend YieldN/A1.56%2.78%4.08%
P/E Ratio-7.6323.5628.3526.03
Price / Sales45.4948.94990.50104.41
Price / CashN/A39.8225.5828.79
Price / Book21.806.946.766.06
Net Income-$7.43M$34.86M$197.91M$265.83M
7 Day Performance61.51%4.26%11.74%2.98%
1 Month Performance60.66%-3.54%4.02%0.26%
1 Year PerformanceN/A54.44%44.77%18.26%

Safe Pro Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPAI
Safe Pro Group
0.9192 of 5 stars
$6.11
-10.1%
$8.00
+31.0%
N/A$98.72M$2.17M-7.6311High Trading Volume
STIM
Neuronetics
1.4007 of 5 stars
$3.42
-3.5%
$7.00
+105.0%
+231.6%$227.14M$111.11M-3.04180Positive News
NYXH
Nyxoah
2.4574 of 5 stars
$6.47
-1.6%
$15.00
+132.0%
-21.6%$220.20M$4.89M-3.04110Gap Up
SGHT
Sight Sciences
1.4292 of 5 stars
$4.12
-1.8%
$4.27
+3.7%
-37.7%$216.29M$79.87M-4.30210
SI
Shoulder Innovations
3.4363 of 5 stars
$13.97
-2.5%
N/AN/A$212.75M$34.57M-0.4761News Coverage
Analyst Forecast
Gap Up
INGN
Inogen
4.3186 of 5 stars
$7.53
-0.3%
$11.00
+46.1%
-38.4%$203.61M$335.70M-7.101,030Positive News
INFU
InfuSystem
3.5089 of 5 stars
$9.46
-0.8%
$12.50
+32.2%
N/A$193.13M$139.89M157.61410
KRMD
KORU Medical Systems
1.0225 of 5 stars
$4.15
-1.5%
$4.63
+11.6%
+78.7%$191.67M$33.65M-46.0680
CVRX
CVRx
2.5023 of 5 stars
$7.25
+5.5%
$14.00
+93.2%
-14.7%$189.33M$51.29M-3.45160Positive News
MGRM
Monogram Orthopaedics
1.9304 of 5 stars
$5.30
-0.5%
$5.40
+2.0%
+56.7%$188.98M$370K-10.5928
CV
CapsoVision
N/A$3.99
-0.3%
$5.50
+37.8%
N/A$184.91M$12.52M0.0090

Related Companies and Tools


This page (NASDAQ:SPAI) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners